Skip to main content

Regeneron DRC A Double Masked Randomized, Controlled Study of the Efficacy and Safety of Intravitreal Administration of VEGF Trap-Eye in Patients with Diabetic Macular Edema Regeneron VGFT-1009 - Extension

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

Regeneron Pharmaceuticals, Inc.

Start Date

April 6, 2020

End Date

October 1, 2022
 

Administered By

Ophthalmology

Awarded By

Regeneron Pharmaceuticals, Inc.

Start Date

April 6, 2020

End Date

October 1, 2022